{"version": "1.2.0", "chapters": [{"title": "Exploring Abbott's Heart Failure Business and Digital Healthcare Innovation", "startTime": 0}, {"title": "Transforming OEMs with Connectivity and Predictive Maintenance", "startTime": 216}, {"title": "Dr. Finn Gustafsson's Journey from Academia to Abbott Heart Failure", "startTime": 354}, {"title": "Understanding Heart Failure and Abbott's Heart Failure Portfolio", "startTime": 680}, {"title": "Heart Monitoring Devices Enhance Patient Care and Empowerment", "startTime": 1083}, {"title": "AI-Driven Healthcare Innovation and Regulatory Navigation", "startTime": 1541}, {"title": "Advancements and Patient Impact of HeartMate 3 in Heart Failure", "startTime": 1760}, {"title": "Reducing Bleeding Risks in HeartMate 3 Patients Without Aspirin", "startTime": 2479}, {"title": "Advancements and Future Directions in LVAD Technology and Treatment", "startTime": 2565}, {"title": "Exploring MedTech Innovations and Patient Choices in Heart Devices", "startTime": 2716}]}